SCHEMBL19952992

SCHEMBL19952992

Fc1ccc(/N=C/c2c(F)ccc(F)c2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.42
CA12 O43570 3/20 0.42
CA2 P00918 3/20 0.42
CA9 Q16790 3/20 0.42
CA1 P00915 2/20 0.42
PTGS1 P23219 1/20 0.42
ALDH1A1 P00352 5/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
KDM4E B2RXH2 4/20 0.37
KMT2A Q03164 3/20 0.37
GAA P10253 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ALOX12 P18054 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953160 0.91 CYP1A2 (0.46) CA12CA2CA9CA1ALDH1A1
SCHEMBL19967342 0.86 MAPT (0.41) PTGS2CA12CA2CA9CA1
SCHEMBL11406035 0.79 PTGS2 (0.46) PTGS2CA12CA2CA9CA1
SCHEMBL11406038 0.79 PTGS2 (0.46) PTGS2CA12CA2CA9CA1
SCHEMBL1163846 0.76 CYP1A2 (0.46) CA12CA2CA9CA1ALDH1A1
SCHEMBL1163845 0.76 CYP1A2 (0.46) CA12CA2CA9CA1ALDH1A1
SCHEMBL19953197 0.76 CYP1A2 (0.46) CA12CA2CA9CA1ALDH1A1
SCHEMBL1110733 0.74 CYP1A2 (0.45) PTGS2CA12CA2CA9CA1
SCHEMBL11416385 0.73 CA1 (0.57) PTGS2CA12CA2CA9CA1
SCHEMBL28398293 0.73 CA1 (0.57) PTGS2CA12CA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed